Minimal Clinically Important Differences in Quality of Life Scores of Oral Cavity and Oropharynx Cancer Patients
Authors:
- 8 April 2014
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 21 (8) , 2773-2781
Abstract
The minimal clinically important difference (MCID) is defined as the smallest difference in quality of life (QOL) that patients perceive as beneficial and that mandates a change in management. We aimed to determine the MCID among patients with oral cavity and oropharyngeal cancer and to identify domains that are significantly affected during treatment. The cohort consisted of 1,011 patients analyzed by a metaanalysis according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. MCID values for the University of Washington Quality of Life Questionnaire (UW-QOLQ) and European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC C-30) and Head and Neck-35 questionnaires were calculated by using the distribution-based method. The mean MCID for Global QOL was 13.07 points for the UW-QOLQ and 9.43 in the EORTC C-30 questionnaire. High consistency in the MCID values was found between the two questionnaires examined. Heat map analysis indicated a clinically significant improvement in head and neck-associated domains and in domains associated with general cancer treatment 1 year or more after treatment relative to 3 months after treatment (p < 0.001 and p = 0.016, respectively). In contrast, improvement in general and functional domains was not evident 1 year or more after treatment (p = 0.69). This study suggests benchmark values for MCID and variation in QOL scores of oral and oropharyngeal cancer patients after treatment. Improvement in head and neck- and general cancer-associated domains may not be translated into a general and functional improvement during the first year of recovery.Keywords
This publication has 36 references indexed in Scilit:
- Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinomaEuropean Journal of Cancer, 2010
- Intensity-Modulated Chemoradiotherapy Aiming to Reduce Dysphagia in Patients With Oropharyngeal Cancer: Clinical and Functional ResultsJournal of Clinical Oncology, 2010
- A Second National Survey of Health-Related Quality of Life Questionnaires in Head and Neck OncologyThe Annals of The Royal College of Surgeons of England, 2009
- Quality of life and functional status in patients with cancer of the oral cavity and oropharynx: pretreatment values of a prospective studyEuropean Archives of Oto-Rhino-Laryngology, 2007
- Patients’ perceived health status following primary surgery for oral and oropharyngeal cancerInternational Journal of Oral and Maxillofacial Surgery, 2006
- Hypercalcemic complication in patients with oral squamous cell carcinomaInternational Journal of Oral and Maxillofacial Surgery, 2003
- Quality of life 2–10 years after combined treatment for advanced oral and oropharyngeal cancerInternational Journal of Oral and Maxillofacial Surgery, 2002
- A comparison of aesthetic, functional and patient subjective outcomes following lip-split mandibulotomy and mandibular lingual releasing access proceduresInternational Journal of Oral and Maxillofacial Surgery, 2001
- Clinically significant change: Jacobson and Truax (1991) revisited.Journal of Consulting and Clinical Psychology, 1992
- Measurement of health statusControlled Clinical Trials, 1989